• Home
  • News
  • CPhI newcomer Holochem, a brand-new CRO offering fine chemical R&D services for the development of key intermediates and exclusive APIs

CPhI newcomer Holochem, a brand-new CRO offering fine chemical R&D services for the development of key intermediates and exclusive APIs

October 2017

The fine chemical industry counts a new player with a highly experienced R&D and executive management team. Holochem, CPhI newcomer founded by former Sanofi executive and Holis Technologies CEO Serge Calet, is a customer-oriented Contract Research Organization.

The company offers R&D services for the development of key intermediates and Active Pharmaceutical Ingredients, and produces pre-clinical batched for early-phase formulation and toxicological use.

Read more

Trackback from your site.